Blue Line Capital’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
Blue Line Capital's EW Position: Q3 2026 in Review
Blue Line Capital increased its Edwards Lifesciences (EW) stake by 1.7% in Q3 2026, buying an estimated $16.8K and bringing the position to 11,090 shares worth $957K. The position accounts for 0.74% of the portfolio, ranked #42.
Blue Line Capital first reported a position in EW in Q4 2025 and has held it in 4 quarters since. The position peaked at $986K in Q2 2026. 1,342 funds tracked by Wall St. Rank hold EW as of Q3 2026.
- Blue Line Capital held 11,090 shares of Edwards Lifesciences worth $957K as of Q3 2026.
- Blue Line Capital bought 189 Edwards Lifesciences shares in Q3 2026, an estimated $16.8K.
- Edwards Lifesciences made up 0.74% of Blue Line Capital's portfolio in Q3 2026, its #42 holding.
- Blue Line Capital first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 4 quarters since.
- Blue Line Capital's Edwards Lifesciences position peaked at $986K in Q2 2026.
- 1,342 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.
Based on Blue Line Capital's 13F filing for Q3 2026, filed 4 Nov 2026.